Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

AIM: To study cerebrospinal fluid (CSF) concentrations of plasminogen activator inhibitor type-1 (PAI-1) in patients with neurological disease. METHODS: CSF PAI-1 concentrations were measured in 51 patients with neurological disease and 20 reference subjects using an ELISA. The patient group compris...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Akenami, F O, Koskiniemi, M, Färkkilä, M, Vaheri, A
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1997
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC499743/
https://ncbi.nlm.nih.gov/pubmed/9155699
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk